Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10920-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10920-1-AP, RRID:AB_2202239
- Product name
- THOC1 antibody
- Antibody type
- Polyclonal
- Description
- THOC1 antibody (Cat. #10920-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, IP, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Circ_0119872 promotes uveal melanoma development by regulating the miR-622/G3BP1 axis and downstream signalling pathways.
Post-transcriptional repression of circadian component CLOCK regulates cancer-stemness in murine breast cancer cells.
TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition.
Elevated expression of Thoc1 is associated with aggressive phenotype and poor prognosis in colorectal cancer.
The suppression of thoc1 in cancer cell apoptosis mediated by activated macrophages is nitric oxide-dependent.
Liu S, Chen L, Chen H, Xu K, Peng X, Zhang M
Journal of experimental & clinical cancer research : CR 2021 Feb 12;40(1):66
Journal of experimental & clinical cancer research : CR 2021 Feb 12;40(1):66
Post-transcriptional repression of circadian component CLOCK regulates cancer-stemness in murine breast cancer cells.
Ogino T, Matsunaga N, Tanaka T, Tanihara T, Terajima H, Yoshitane H, Fukada Y, Tsuruta A, Koyanagi S, Ohdo S
eLife 2021 Apr 23;10
eLife 2021 Apr 23;10
TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition.
Liu SL, Lin HX, Lin CY, Sun XQ, Ye LP, Qiu F, Wen W, Hua X, Wu XQ, Li J, Song LB, Guo L
Cancer letters 2017 Aug 28;402:117-130
Cancer letters 2017 Aug 28;402:117-130
Elevated expression of Thoc1 is associated with aggressive phenotype and poor prognosis in colorectal cancer.
Liu C, Yue B, Yuan C, Zhao S, Fang C, Yu Y, Yan D
Biochemical and biophysical research communications 2015 Dec 4-11;468(1-2):53-8
Biochemical and biophysical research communications 2015 Dec 4-11;468(1-2):53-8
The suppression of thoc1 in cancer cell apoptosis mediated by activated macrophages is nitric oxide-dependent.
Lin YS, Lin CH, Huang LD, Chao T, Kuo CD, Hung LC, Wong FH, Lin CC, Fu SL
Biochemical pharmacology 2013 Jul 15;86(2):242-52
Biochemical pharmacology 2013 Jul 15;86(2):242-52
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HEK-293 cells were subjected to SDS PAGE followed by western blot with 10920-1-AP(THOC1 antibody) at dilution of 1:500
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The THOC1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human THOC1. This antibody recognizes human,mouse,rat antigen. The THOC1 antibody has been validated for the following applications: ELISA, WB, IHC analysis.